Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Phase 3 data expected in the second half of 2024
The company has raised US$4.5 million in funding for its AI operating system
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The initiative will focus on advocating for cleaner air
RHTC will address a long-standing healthcare access issue for all the local population
Subscribe To Our Newsletter & Stay Updated
